drug
WEZLANA
Marketedupdated 6mo agoby $AMGN AMGEN INC
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 4all catalysts(6)
approval · 6
Oct 31, 2023
approval
$AMGN462.32-0.72%
WEZLANA (USTEKINUMAB-AUUB) — FDA approval
WEZLANA
→
Oct 31, 2023
approval
$AMGN462.32-0.72%
WEZLANA (USTEKINUMAB-AUUB) — FDA approval
WEZLANA
→
Dec 26, 2024
approval
$AMGN462.32-0.72%
WEZLANA (USTEKINUMAB-AUUB) — FDA approval
WEZLANA
→
Dec 26, 2024
approval
$AMGN462.32-0.72%
WEZLANA (USTEKINUMAB-AUUB) — FDA approval
WEZLANA
→
Sep 25, 2025
approval
$AMGN462.32-0.72%
WEZLANA (USTEKINUMAB-AUUB) — FDA approval
WEZLANA
→
Sep 25, 2025
approval
$AMGN462.32-0.72%
WEZLANA (USTEKINUMAB-AUUB) — FDA approval
WEZLANA
→
News(1)
- 5 new drug launches that defied industry expectationsA clearly superior clinical profile, reasonable pricing and easy access has helped a handful of recently approved therapies achieve impressive launches.biospace · 20d ago
Data sources
last refreshed 4h ago
Found something off?
comments(0)
5-min edit window · permanent after that